The peptide stimulates release of luteinizing hormone (LH), which in men signals testosterone production and in women supports ovulation and progesterone synthesis
shermanii are more commonly used today
BPC-157 enhances this entire system, resulting in faster and more efficient migration of fibroblasts and other repair cells
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors
This level suits researchers primarily interested in metabolic health improvements like insulin sensitivity and lipid panel normalization, where extreme weight loss is not the primary goal
BPC 157 has shown significant promise in treating various conditions, including neurological recovery and wound healing, due to its robust cytoprotective properties